WHO urges countries to invest more in research to prevent TB transmission

New Delhi: On the eve of the World TB Day, the World Health Organisation on Friday urged the countries to harness the power of technology for early diagnosis of tuberculosis while stressing on more investment into research to prevent its transmission.

WHO regional director for South-east Asia, Dr Poonam Khetrapal Singh, also asked the countries to ensure all persons that have had contact with a TB patient are traced and also screened for the disease.

“Similarly, greater attention should be given to managing latent TB lest it become active, especially for persons living with HIV. Investing in research aimed at developing tools to prevent TB transmission (and that can be applied to large populations) should likewise be prioritized,” Singh said.

She termed the recent region-wide progress as both significant and highly encouraging, and lauded the member countries for increasing their domestic funding for TB programmes with two of them have done so by more than 100 per cent.

“All member countries have accelerated active case-finding. Patient-centered policies have been developed and implemented, including direct cash transfers and nutritional support for persons suffering TB and plans have been developed to engage civil society organizations,” she said.

Maintaining the Region’s leadership, drive and momentum ahead of September’s High-Level Meeting on TB, which will occur alongside the UN General Assembly, is of vital importance, she said while seeking commitment from all levels of society, starting from the highest offices of government to community health workers and volunteers.

  • Related Posts

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    New Delhi: Aurobindo Pharma Ltd on Friday said it has received final approval from the US health regulator to manufacture and market its generic version of glycerol phenylbutyrate oral liquid…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India